Crossmark

Clinical effectiveness of oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during Omicron JN.1 subvariant wave: a US-based propensity-matched cohort study

Crossref DOI link: https://doi.org/10.1186/s41479-025-00168-w

Published Online: 2025-05-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hsu, Wan-Hsuan

Shiau, Bo-Wen

Huang, Po-Yu

Tsai, Ya-Wen

Wu, Jheng-Yan

Liu, Ting-Hui

Chuang, Min-Hsiang

Tey, Shu-Farn

Hung, Lun-Wu

Lai, Chih-Cheng
License Information

Text and Data Mining valid from 2025-05-25

Version of Record valid from 2025-05-25
More Information

Article History

Received: 29 July 2024

Accepted: 28 March 2025

First Online: 25 May 2025

Declarations

:

: This study was conducted in accordance with in accordance with the Declaration of Helsinki. Written informed consent was not required because TriNetX contains anonymized data. The Institutional Review Board of the Chi Mei Medical Center approved the study protocol (no. 11202–002).

: No.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below